{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:52:51Z","timestamp":1760244771267,"version":"build-2065373602"},"reference-count":149,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research and Public Service Institution of Bandung Institute of Technology","award":["223\/IT1.Bo7.1\/TA.00\/2022"],"award-info":[{"award-number":["223\/IT1.Bo7.1\/TA.00\/2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Viruses are the current big enemy of the world\u2019s healthcare systems. As the small infector causes various deadly diseases, from influenza and HIV to COVID-19, the virus continues to evolve from one type to its mutants. Therefore, the development of antivirals demands tremendous attention and resources for drug researchers around the world. Active pharmaceutical ingredients (API) development includes discovering new drug compounds and developing existing ones. However, to innovate a new antiviral takes a very long time to test its safety and effectiveness, from structure modeling to synthesis, and then requires various stages of clinical trials. Meanwhile, developing the existing API can be more efficient because it reduces many development stages. One approach in this effort is to modify the solid structures to improve their physicochemical properties and enhance their activity. This review discusses antiviral multicomponent systems under the research phase and has been marketed. The discussion includes the types of antivirals, their counterpart compound, screening, manufacturing methods, multicomponent systems yielded, characterization methods, physicochemical properties, and their effects on their pharmacological activities. It is hoped that the opportunities and challenges of solid antiviral drug modifications can be drawn in this review as important information for further antiviral development.<\/jats:p>","DOI":"10.3390\/molecules27249051","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T09:05:09Z","timestamp":1671440709000},"page":"9051","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-Covalent Reactions Supporting Antiviral Development"],"prefix":"10.3390","volume":"27","author":[{"given":"Ilma","family":"Nugrahani","sequence":"first","affiliation":[{"name":"School of Pharmacy, Bandung Institute of Technology, Bandung 40132, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emy","family":"Susanti","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Bandung Institute of Technology, Bandung 40132, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tazkia","family":"Adawiyah","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Bandung Institute of Technology, Bandung 40132, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safira","family":"Santosa","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Bandung Institute of Technology, Bandung 40132, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnesya Namira","family":"Laksana","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Bandung Institute of Technology, Bandung 40132, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Perles, J. (2020). Characterisation and Study of Compounds by Single Crystal X-ray Diffraction. Crystals, 10.","DOI":"10.3390\/cryst10100934"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/1570179416666190718153703","article-title":"Multicomponent reactions for thee synthesis of bioactive compounds: A review","volume":"16","author":"Cedric","year":"2019","journal-title":"Curr. Org. Synth."},{"key":"ref_3","first-page":"206","article-title":"Acemetacin cocrystal structures by powder x-ray diffraction","volume":"4","author":"Bolla","year":"2017","journal-title":"Int. Euro. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"8199","DOI":"10.1021\/acsomega.0c06239","article-title":"Synthesis and characterization of a (-)-epicatechin and barbituric acid cocrystal: Single crystal x-ray diffraction and vibrational spectroscopic stduies","volume":"6","author":"Maciolek","year":"2021","journal-title":"ACS Omega"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1021\/acs.cgd.2c00044","article-title":"Extending the Range of Nitrofurantoin Solid Forms: Effect of Molecular and Crystal Structure on Formation Thermodynamics and Physicochemical Properties","volume":"22","author":"Surov","year":"2022","journal-title":"Cryst. Growth Des."},{"key":"ref_6","first-page":"3054","article-title":"Mechanochemical Synthesis of Pharmaceutical Cocrystal Suspensions via Hot Melt Extrusion: Feasibility Studies and Physicochemical Characterization Molecular","volume":"13","author":"Li","year":"2016","journal-title":"Pharmaceutics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1021\/mp400516b","article-title":"Salt and Cocrystals of Sildenafil with Dicarboxylic Acids: Solubility and Pharmacokinetic Advantage of the Glutarate Salt","volume":"10","author":"Sanphui","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"126601","DOI":"10.1016\/j.jcrysgro.2022.126601","article-title":"Solubility and dissolution rate of progesterone cocrystals using 4-fluorobenzoic acid and 2-hydroxy-6-naphthoic acid as coformers","volume":"585","author":"Yunxia","year":"2022","journal-title":"J. Cryst. Growth"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1016\/j.xphs.2021.05.022","article-title":"New Sodium Mefenamate\u2013Nicotinamide Multicomponent Crystal Development to Modulate Solubility and Dissolution: Preparation, Structural, and Performance Study","volume":"110","author":"Nugrahani","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Nugrahani, I., Tjengal, B., Gusdinar, T., Horikawa, A., and Uekusa, H. (2020). A Comprehensive Study of a New 1.75 Hydrate of Ciprofloxacin Salicylate: SCXRD Structure Determination, Solid Characterization, Water Stability, Solubility, and Dissolution Study. Crystals, 10.","DOI":"10.3390\/cryst10050349"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejps.2018.02.020","article-title":"Zwitterionic cocrystal of diclofenac and l-proline: Structure determination, solubility, kinetics of cocrystallization, and stability study","volume":"117","author":"Nugrahani","year":"2018","journal-title":"Europ. J. Pharm. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1021\/acs.cgd.1c00437","article-title":"Improving Stability of Vitamin B5 Through Double Salt Formation","volume":"21","author":"Liang","year":"2021","journal-title":"Cryst. Growth"},{"key":"ref_13","first-page":"929","article-title":"Discovery of the first virus, the tobacco mosaic virus: 1892 or 1898?","volume":"324","author":"Lecoq","year":"2001","journal-title":"Comptes Rendus L\u2019academie Sci. Ser. III Sci. Vie"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejphar.2014.06.053","article-title":"Activity of antibacterial, antiviral, anti-inflammatory in compounds andrographolide salt","volume":"740","author":"Wen","year":"2014","journal-title":"Euro. J. Pharm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.partic.2021.03.015","article-title":"Co-crystals of non-steroidal anti-inflammatory drugs (NSAIDs): Insight toward formation, methods, and drug enhancement","volume":"58","author":"Nascimento","year":"2021","journal-title":"Particuology"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chen, L., Hu, C., Hood, M., Zhang, X., Zhang, L., Kan, J., and Du, J. (2020). A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis. MPI, 12.","DOI":"10.3390\/nu12041193"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2014.07.008","article-title":"Novel pharmaceutical cocrystal consisting of paracetamol and trimethylglycine, a new promising cocrystal former","volume":"473","author":"Maeno","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2015.12.001","article-title":"Physicochemical and mechanical properties of paracetamol cocrystal with 5-nitroisophthalic acid","volume":"497","author":"Hiendrawan","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_19","first-page":"277","article-title":"Solubility enhancement of lornoxicam by crystal engineering","volume":"79","author":"Gadade","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1021\/cg8007359","article-title":"Co-crystals of the anti-HIV drugs lamivudine and zidovudine","volume":"9","author":"Bhatt","year":"2009","journal-title":"Cryst. Growth Des."},{"key":"ref_21","unstructured":"Blazecka, P.G., Che, D., McPhail, C.L., and Rey, A.W. (2011). Salt form and cocrystal of adevofit dipivoxil and processes for preparation thereof. (US 7,935,817 B2), United States Patent."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10973-018-7696-7","article-title":"Investigation and characterization by TG\/DTG-DTA and DSC of the fusion of riboflavin, and its interaction with the antibiotic norfloxacin in the screening of cocrystal","volume":"136","author":"Ferreira","year":"2019","journal-title":"J. Therm. Anal. Cal."},{"key":"ref_23","first-page":"154","article-title":"A nano-crystal strategy to improve the dissolution rate and oral bioavailability of baicalein","volume":"14","author":"Pi","year":"2019","journal-title":"Asian J. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"Clercq","year":"2004","journal-title":"J. Clin. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Vardanyan, R., and Hruby, V. (2016). Antiviral Drugs: Synthesis of Best-Seller Drugs, Academic Press.","DOI":"10.1016\/B978-0-12-411492-0.00034-1"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"116356","DOI":"10.1016\/j.bmc.2021.116356","article-title":"Antiviral strategies targeting host factors and mechanisms obliging +ssRNA viral pathogens","volume":"46","author":"Mahajan","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1007\/s11270-012-1410-3","article-title":"Occurance and removal of antiviral drugs in environment: A review","volume":"224","author":"Jain","year":"2013","journal-title":"Water Air Soil Pollut."},{"key":"ref_29","unstructured":"National Center for Biotechnology Information (2022, December 04). PubChem Compound Summary for CID 135398513, Acyclovir, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Acyclovir."},{"key":"ref_30","unstructured":"National Center for Biotechnology Information (2022, December 04). PubChem Compound Summary for CID 563244, Indinavir, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Indinavir#section=Structures."},{"key":"ref_31","unstructured":"National Center for Biotechnology Information (2022, December 04). PubChem Compound Summary for CID 4463, Nevirapine, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Nevirapine#section=2D-Structure."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Le Pevelen, D.D., and Tranter, G.E. (2017). Encyclopedia of Spectroscopy and Spectrometry: FT-IR and Raman Spectroscopies, Polymorphism Applications, Academic Press. [3rd ed.].","DOI":"10.1016\/B978-0-12-409547-2.12161-4"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1021\/acs.cgd.0c00357","article-title":"Polymorphs and Transformations of the Solid Forms of Organic Salts of 5-Sulfosalicylic Acid and Isonicotinamide","volume":"20","author":"Duan","year":"2020","journal-title":"Cryst. Growth Des."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1021\/acs.cgd.6b00200","article-title":"Solvates, Salts, and Cocrystals: A Proposal for a Feasible Classification System","volume":"16","author":"Grothe","year":"2016","journal-title":"Cryst. Growth Des."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Caira, M.R. (2008). Handbook of Thermal Analysis and Calorimetry: Polymorphism, Elsevier Science B.V. Chapter 16.","DOI":"10.1016\/S1573-4374(08)80019-2"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.antiviral.2012.05.010","article-title":"Identification of substituted [3, 2-a] pyrimidines as selective antiviral agents: Molecular modeling study","volume":"95","author":"Babu","year":"2012","journal-title":"Antivir. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejps.2015.10.006","article-title":"Mechanism study on stability enhancement of adefovir dipivoxil by cocrystallization: Degradation kinetics and structure-stability correlation","volume":"85","author":"Lin","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Deb, P.K., Abed, S.N., Maher, H., Al-Aboudi, A., Paradkar, A., Bandopadhyay, S., and Tekade, R.K. (2020). Drug Delivery Systems: Arosols in Pharmaceutical Product Development, Academic Press. Chapter 11.","DOI":"10.1016\/B978-0-12-814487-9.00011-9"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Pathak, K. (2021). Advance and Challenges in Phamaceutical Technology: Effective Formulation Strategies for Poorly Water Soluble Drugs, Academic Press. Chapter 6.","DOI":"10.1016\/B978-0-12-820043-8.00004-9"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1021\/acs.molpharmaceut.5b00629","article-title":"New solid forms of the antiviral drug arbidol: Crystal structures, thermodynamic stability, and solubility","volume":"12","author":"Surov","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_41","unstructured":"Tiekink, E.R., and Schpector, J.Z. (2018). Pharmaceutical co-crystals: Crystal engineering and applications. Multi-Component Crystals: Synthesis, Concepts, Function, De Gruyter."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1039\/C5CC08216A","article-title":"Pharmaceutical cocrystals: Along the path to improved medicine","volume":"52","author":"Duggirala","year":"2016","journal-title":"Chem. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1021\/acs.jced.8b00560","article-title":"Solubility Determination of Nicotinamide and Its Application for the Cocrystallization with Benzoic Acid","volume":"63","author":"Ouyang","year":"2018","journal-title":"J. Chem. Eng. Data"},{"key":"ref_44","first-page":"1","article-title":"New trends in the co-crystallization of active pharmaceutical ingridients","volume":"1","author":"Nanjwade","year":"2011","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_45","first-page":"969","article-title":"Sustainable pharmaceutical preparation methods and solid state analysis supporting green pharmacy","volume":"17","author":"Nugrahani","year":"2020","journal-title":"Pharm. Anal."},{"key":"ref_46","first-page":"57","article-title":"Development of the NSAID-L-Proline amino acid","volume":"8","author":"Nugrahani","year":"2018","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.addr.2016.04.022","article-title":"Cocrystal to facilitate delivery of poorly soluble compoundsbeyond-rule-of-5","volume":"101","author":"Kuminek","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.poly.2018.06.049","article-title":"Coordination aspects in Schiff bases cocrystal","volume":"115","author":"Golbedaghi","year":"2018","journal-title":"Polyhedron"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1021\/acs.cgd.8b00668","article-title":"Tracking cocrystallization of active pharmaceutical ingridients with benzoic acids coformer using broadband acoustic resonance dissolution spectroscopy","volume":"18","author":"Kent","year":"2018","journal-title":"Cryst. Growth Des."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5530\/srp.2018.1.15","article-title":"Traditional and novel methods for cocrystal formation: A mini review","volume":"9","author":"Barikah","year":"2018","journal-title":"Syst. Rev. Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1021\/acs.cgd.0c00075","article-title":"A Sulfathiazole-Amantadine Hydrochloride Cocrystal: The First Codrug Simultaneously Comprising Antiviral and Antibacterial Components","volume":"20","author":"Wang","year":"2020","journal-title":"Cryst. Growth Des."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Thakuria, R., and Sarma, D. (2018). Drug-drug and drug-neutraceutical cocrystal\/salt as alternative medicine for combination therapy: A crystal engineering approach. Crystals, 8.","DOI":"10.3390\/cryst8020101"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1021\/acs.cgd.8b01929","article-title":"Comparative study of the ionic cocrystal NaX","volume":"19","author":"Linberg","year":"2019","journal-title":"Cryst. Growth Des."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"135","DOI":"10.22159\/ajpcr.2017.v10i5.15863","article-title":"Mefenamic Acid-Nicotinamide Co-Crystal Synthesized By Using Melt Crystallization Method And Its Solubility Study","volume":"10","author":"Utami","year":"2017","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1021\/acs.cgd.0c00374","article-title":"Cocrystals of Penciclovir with Hydroxybenzoic Acids: Synthesis, Crystal Structures, and Physicochemical Evaluation","volume":"20","author":"Yuan","year":"2020","journal-title":"Cryst. Growth Des."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"128052","DOI":"10.1016\/j.molstruc.2020.128052","article-title":"A study on interwoven hydrogen bonding interactions in new zidovudine-picric acid (1:1) cocrystal through single crystal XRD, spectral and computational methods","volume":"1211","author":"Likhitha","year":"2020","journal-title":"J. Mol. Struct."},{"key":"ref_57","unstructured":"Nugrahani, I., Asyarie, S., Soewandhi, S.N., and Ibrahim, S. (2007). Chemical-Physical Interaction Identification in Amoxicillin Trihydrate-Clavulanate Potassium Antibiotic Combination with Solvent Calorimetry and Recrystallization. Pharm. Mag., 4."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1021\/cg3018002","article-title":"Toward Novel Solid state Forms of the Anti-HIV Drug Efavirenz: From Low Screening Success to Cocrystals Engineering Strategies and Discovery of a New Polymorph","volume":"13","author":"Melo","year":"2013","journal-title":"Cryst. Growth Des."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Nugrahani, I., Laksana, A.N., Uekusa, H., and Oyama, H. (2022). New organic salt from levofloxacin-citric acid: What is the impact on the stability and antibiotic potency?. Molecules, 27.","DOI":"10.3390\/molecules27072166"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1021\/acs.cgd.8b00933","article-title":"Creating cocrystals: A review of pharmaceutical cocrystal preparation routes and applications","volume":"18","author":"Padrela","year":"2018","journal-title":"Cryst. Growth. Des."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ces.2015.01.045","article-title":"Design of co-\u0107rystallization processes with regard to particle size distribution","volume":"128","author":"Ridvan","year":"2015","journal-title":"Chem. Eng. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.matpr.2016.04.069","article-title":"Development of efavirenz cocrystals from stoichiometric solutions by spray drying technology","volume":"3","author":"Jaywant","year":"2016","journal-title":"Mater. Today Proc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1021\/cg401179s","article-title":"Cocrystallization by freeze-drying: Preparation of novel multicomponent crystal forms","volume":"13","author":"Eddleston","year":"2013","journal-title":"Cryst. Growth Des."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jpba.2019.03.014","article-title":"At-line green synthesis monitoring, new pharmaceutical co-crystals lamivudine:theophylline polymorph I and Il, quantification of polymorph I among its API using FI-IR spectroscopy and MCR-ALS","volume":"30","author":"Mazivilaa","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e02946","DOI":"10.1016\/j.heliyon.2019.e02946","article-title":"Cocrystal construction between the athyl etil with parent drug of diclofenac structural, stability, and anti-inflamatory study","volume":"5","author":"Nugrahani","year":"2019","journal-title":"Heliyon"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3390\/cryst5040583","article-title":"Liquid-assisted grinding to prepare a cocrystal of adefovir dipivoxil thermodynamically less stable than its neat phase","volume":"5","author":"Jung","year":"2015","journal-title":"Crystals"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Nugrahai, I., and Jessica, A.M. (2021). Amino Acids as the Potential Co-Former for Co-Crystal Development: A Review. Molecules, 26.","DOI":"10.3390\/molecules26113279"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1021\/acs.cgd.7b01600","article-title":"Salts and salt cocrystals of the antibacterial drug perfloxacin","volume":"18","author":"Gunaam","year":"2018","journal-title":"Cryst. Growth Des."},{"key":"ref_69","unstructured":"Wilson, J.M., Newcombe, R.J., and Denaro, A.R. (2016). Experiments in Physical Chemistry, Pergamon Press. [2nd ed.]. Experiment 10."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2018.12.027","article-title":"Emodin-nicotinamide (1:2) cocrystal identified by thermal screening to improve emodin solubility","volume":"557","author":"Park","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcrysgro.2012.10.044","article-title":"Structures and physical properties of the cocrystals of adefovir dipivoxil with dicarboxylic acids","volume":"373","author":"Jung","year":"2013","journal-title":"J Cryst. Growth"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3390\/cryst5040650","article-title":"Crystalstructures, thermal analysis, and dissolution behavior of new solid forms of the antiviral drug arbidol with dicarboxylic acids","volume":"5","author":"Manin","year":"2015","journal-title":"Crystals"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"178782","DOI":"10.1016\/j.tca.2020.178782","article-title":"A norfloxacin-nicotinic acid cocrystal: Mechanochemical synthesis, thermal and structural characterization, and solubility assays","volume":"694","author":"Ferreira","year":"2020","journal-title":"Thermochim. Acta"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.xphs.2020.08.002","article-title":"Composing Novel Diclofenac Potassium and l-Proline Salt Cocrystal as a Strategy to Increase Solubility and Dissolution","volume":"109","author":"Nugrahani","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Nugrahani, I., Kumalasari, R.A., Auli, W.N., Horikawa, A., and Uekusa, H. (2020). Salt Cocrystal of Diclofenac Sodium-L-Proline: Structural, Pseudopolymorphism, and Pharmaceutics Performance Study. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12070690"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Nugrahani, I., and Parwati, D.R. (2021). Challenges and Progress in Nonsteroidal Anti-Inflammatory Drugs Co-Crystal Development. Molecules, 26.","DOI":"10.3390\/molecules26144185"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Salas-Z\u00fa\u00f1iga, R., Rodr\u00edguez-Ruiz, C., H\u00f6pfl, H., Morales-Rojas, H., S\u00e1nchez-Guadarrama, O., Rodr\u00edguez-Cuamatzi, P., and Herrera-Ruiz, D. (2020). Dissolution Advantage of Nitazoxanide Cocrystals in the Presence of Cellulosic Polymers. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12010023"},{"key":"ref_78","first-page":"119","article-title":"Spectral studies of some complexes with chloramphenicol","volume":"3","author":"Guru","year":"2011","journal-title":"Int. J. Chemtech Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"77","DOI":"10.22159\/ijap.2018v10i3.23034","article-title":"Green method for acetaminophen and ibuprofen simultaneous assay in the combination tablet using FTIR","volume":"10","author":"Nugrahani","year":"2018","journal-title":"Int. J. Appl. Pharm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"43","DOI":"10.22159\/ijap.2018v10i4.25682","article-title":"Rapid assay development of diclofenac sodium coated tablet assay using FTIR compared to HPLC method","volume":"10","author":"Nugrahani","year":"2018","journal-title":"Int. J. Appl. Pharm."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.22159\/ijap.2019v11i2.31225","article-title":"The rapid and green hair analysis method development using FTIR for papaverine HCl determination","volume":"11","author":"Nugrahani","year":"2019","journal-title":"Int. J. Appl. Pharm."},{"key":"ref_82","first-page":"43","article-title":"Development and validation analysis of acyclovir tablet content determination method using FTIR","volume":"8","author":"Nugrahani","year":"2016","journal-title":"Int. J. Appl. Pharm."},{"key":"ref_83","first-page":"561","article-title":"FTIR, Dissolution and Anti-viral Activity of Nevirapine Co-crystals","volume":"8","author":"Samsodien","year":"2017","journal-title":"Pharm. Anal. Acta"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1021\/cg100156a","article-title":"Characterization of new cocrystals by rama spectroscopy, powder x-ray diffraction, differential scanning calorimetry, and transmission raman spectroscopy","volume":"10","author":"Elbagerma","year":"2010","journal-title":"Cryst. Growth Des."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2116\/analsci.33.47","article-title":"Raman spectroscopy of pharmaceutical cocrystals in nanosized pores of mesoporous silica","volume":"33","author":"Ohta","year":"2017","journal-title":"Anal. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1021\/ac200907z","article-title":"Terahertz spectroscopy","volume":"83","author":"Baxter","year":"2011","journal-title":"Anal. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1109\/JPROC.2007.898835","article-title":"In: Terahertz Time-Domain Spectroscopy for Material Characterization","volume":"95","author":"Naftaly","year":"2007","journal-title":"Proc. IEEE"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1021\/jp020579i","article-title":"Terahertz spectroscopy","volume":"106","author":"Beard","year":"2002","journal-title":"J. Phys. Chem. B."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Coutaz, J. (2014, January 16\u201323). Terahertz Time-Domain Spectroscopy: Principles and Recent Developments. Proceedings of the XXXIth URSI General Assembly and Scientific Symposium (URSI GASS), Beijing, China.","DOI":"10.1109\/URSIGASS.2014.6929500"},{"key":"ref_90","unstructured":"Garc\u00eda-Garc\u00eda, E., Diez, E., Meziani, Y.M., Vel\u00e1zquez-P\u00e9rez, J.E., and Calvo-Gallcao, J. (2013\u201314, January 12). Proceedings of the 2013 Spanish Conference on Electron Devices, Valladolid, Spain."},{"key":"ref_91","first-page":"1","article-title":"Terahertz Time-Domain Spectroscopy","volume":"1","author":"Ciccarelli","year":"2020","journal-title":"Sci. Video Protoc."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"231101","DOI":"10.1063\/1.5047659","article-title":"Tutorial: An introduction to terahertz time domain spectroscopy (THz-TDS)","volume":"124","author":"Neu","year":"2018","journal-title":"J. Appl. Phys."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/05704928.2011.614305","article-title":"Terahertz time-domain spectroscopy of solid samples: Principles, applications, and challenges","volume":"46","author":"Smith","year":"2011","journal-title":"Appl. Spectrosc. Rev."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1098\/rsta.2003.1321","article-title":"Applications of terahertz spectroscopy to pharmaceutical sciences","volume":"362","author":"Taday","year":"2004","journal-title":"Philos. Trans.-Royal Soc. Math. Phys. Eng. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1063\/1.1343522","article-title":"A direct comparison between terahertz time\u2013domain spectroscopy and far-infrared Fourier transform spectroscopy","volume":"89","author":"Han","year":"2001","journal-title":"J. Appl. Phys."},{"key":"ref_96","unstructured":"Sengupta, A. (2006). Novel Characterization of Materials Using THz Spectroscopic Techniques. [PhD Dissertation, The State University of New Jersey]."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/jps.10307","article-title":"Solid state nuclear magnetic resonance spectroscopy--pharmaceutical applications","volume":"92","author":"Tishmack","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1211\/jpp.59.2.0009","article-title":"Applications of solid state NMR to pharmaceutical polymorphism and related matters","volume":"59","author":"Harris","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/05704920801944338","article-title":"Solid state NMR studies of pharmaceutical systems","volume":"43","author":"Geppi","year":"2008","journal-title":"Appl. Spectrosc. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4155\/fmc.10.200","article-title":"Evolution of solid state NMR in pharmaceutical analysis","volume":"2","author":"Vogt","year":"2010","journal-title":"Future Med. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.trac.2006.07.006","article-title":"Solid state NMR spectroscopy in pharmaceutical research and analysis","volume":"25","author":"Berendt","year":"2006","journal-title":"TrAC Trends Analyt. Chem."},{"key":"ref_102","first-page":"58","article-title":"Advanced approaches to effective solid-state analysis: X-ray diffraction, vibrational spectroscopy and solid-state NMR","volume":"7","author":"Vogt","year":"2010","journal-title":"Am. Pharm. Rev."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1002\/jps.20469","article-title":"Quantitation of crystalline and amorphous forms of anhydrous neotame using 13C CPMAS NMR spectroscopy","volume":"94","author":"Offerdahl","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2004.05.012","article-title":"Solid state NMR and DSC methods for quantifying the amorphous content in solid dosage forms: An application to ball-milling of trehalose","volume":"280","author":"Lefort","year":"2004","journal-title":"Int. J. Pharm."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jps.20759","article-title":"Quantitation of crystalline material within a liquid vehicle using 1H\/19F CP\/MAS NMR","volume":"96","author":"Farrer","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2010.04.017","article-title":"Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state (13)C CPMAS NMR spectroscopy","volume":"394","author":"Virtanen","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/jps.23062","article-title":"Application of 13C CPMAS NMR for qualitative and quantitative characterization of carvedilol and its commercial formulations","volume":"101","author":"Pisklak","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1023\/A:1016027212156","article-title":"Determination of the composition of delavirdine mesylate polymorph and pseudopolymorph mixtures using 13C CP\/MAS NMR","volume":"13","author":"Gao","year":"1996","journal-title":"Pharm. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/mrc.4984","article-title":"Solid state nuclear magnetic resonance studies of hydroxypropylmethylcellulose acetyl succinate polymer, a useful carrier in pharmaceutical solid dispersions","volume":"58","author":"Pugliese","year":"2019","journal-title":"Magn. Reson. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijpharm.2011.02.030","article-title":"New perspectives of 19F MAS NMR in the characterization of amorphous forms of atorvastatin in dosage formulations","volume":"409","author":"Brus","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1023\/A:1018958116349","article-title":"Solid state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins","volume":"16","author":"Kimura","year":"1999","journal-title":"Pharm. Res."},{"key":"ref_112","first-page":"761","article-title":"Investigation of the physical stability of amorphous drug and drug\/polymer melts using variable temperature solid state NMR","volume":"58","author":"Forster","year":"2003","journal-title":"Pharmazie"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2004.05.024","article-title":"Solid state NMR perspective of drug-polymer solid solutions: A model system based on poly(ethylene oxide)","volume":"281","author":"Schachter","year":"2004","journal-title":"Int. J. Pharm."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0731-7085(93)80083-D","article-title":"Solid state NMR and IR for the analysis of pharmaceutical solids: Polymorphs of fosinopril sodium","volume":"11","author":"Brittain","year":"1993","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1021\/mp100205g","article-title":"Analysis of amorphous solid dispersions using 2D solid state NMR and (1)H T(1) relaxation measurements","volume":"7","author":"Pham","year":"2010","journal-title":"Mol. Pharm."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11095-005-2597-4","article-title":"Comparison of molecular mobility in the glassy state between amorphous indomethacin and salicin based on spin-lattice relaxation times","volume":"22","author":"Masuda","year":"2005","journal-title":"Pharm. Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jps.22769","article-title":"Carbon-deuterium rotational-echo double-resonance NMR spectroscopy of lyophilized aspartame formulations","volume":"101","author":"Luthra","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1018891317006","article-title":"The effect of excipients on the molecular mobility of lyophilized formulations, as measured by glass transition temperature and NMR relaxation-based critical mobility temperature","volume":"16","author":"Yoshioka","year":"1999","journal-title":"Pharm. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejps.2005.02.002","article-title":"A solid state NMR study of molecular mobility and phase separation in co-spray-dried protein-sugar particles","volume":"25","author":"Suihko","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1021\/mp100077c","article-title":"Study of the amorphous glibenclamide drug: Analysis of the molecular dynamics of quenched and cryomilled material","volume":"7","author":"Wojnarowska","year":"2010","journal-title":"Mol. Pharm."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1039\/b516057j","article-title":"NMR studies of organic polymorphs and solvates","volume":"131","author":"Harris","year":"2006","journal-title":"Analyst Lond."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1081\/DDC-120003451","article-title":"19F solid state NMR spectroscopic investigation of crystalline and amorphous forms of a selective muscarinic M3 receptor antagonist, in both bulk and pharmaceutical dosage form samples","volume":"28","author":"Wenslow","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1107\/S1600536810027984","article-title":"Potassium clavulanate","volume":"66","author":"Fujii","year":"2010","journal-title":"Acta Crystallogr. Sect. E Struct. Rep. Online"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/acs.accounts.7b00366","article-title":"Application of X-ray diffraction and electron crystallography for solving complex structure problems","volume":"50","author":"Li","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1021\/cg300689m","article-title":"Crystal design approaches for the synthesis of paracetamol co-crystals","volume":"12","author":"Srirambhatla","year":"2012","journal-title":"Cryst. Growth Des."},{"key":"ref_126","first-page":"15","article-title":"Theophylline-Na-Saccharine single crystal isolation for its structure determination","volume":"7","author":"Nugrahani","year":"2015","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1039\/C4CS00129J","article-title":"Single-crystal X-ray diffraction studies on structural transformations of porous coordination polymers","volume":"43","author":"Zhang","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"16768","DOI":"10.1021\/jacs.7b08895","article-title":"Controlling reactivity by geometry in retro-diels\u2013alder reactions under tension","volume":"139","author":"Stevenson","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"7668","DOI":"10.1039\/c3cs35526h","article-title":"Mechanochemical organic synthesis","volume":"42","author":"Wang","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1039\/C1CS15171A","article-title":"Mechanochemistry: Opportunities for new and cleaner synthesis","volume":"41","author":"James","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/pharmaceutics14020300","article-title":"Rational development of a carrier-free dry powder inhalation formulation for respiratory viral infections via quality by design: A drug-drug cocrystal of favipiravir and theophylline","volume":"14","author":"Wong","year":"2022","journal-title":"Pharmaceutics"},{"key":"ref_132","first-page":"3398","article-title":"Solubility improvement of curcumin with amino acids","volume":"23","author":"Gunnam","year":"2021","journal-title":"Sci. Eng. Res. Board"},{"key":"ref_133","unstructured":"National Center for Biotechnology Information (2022, December 04). PubChem Compound Summary for CID 35370, Zidovudine, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Zidovudine."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1021\/acs.cgd.1c00339","article-title":"Mechanosynthesis, characterization, and physicochemical property investigation of favipiravir cocrystal with theophylline and GRAS coformers","volume":"21","author":"Deka","year":"2021","journal-title":"Cryst. Growth Des."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/acs.cgd.1c01051","article-title":"Enhanced solubility, dissolution, and permeability of abacavir by salt and cocrystal formation","volume":"22","author":"Ji","year":"2022","journal-title":"Cryst. Growth Des."},{"key":"ref_136","first-page":"39","article-title":"Crystal engineering of quercetin by liquid assisted grinding method","volume":"81","author":"Athiyah","year":"2019","journal-title":"J. Teknol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4314\/tjpr.v18i4.3","article-title":"Co-crystallization of quercetin and isonicotinamide using solvent evaporation method","volume":"18","author":"Wisudyaningsih","year":"2021","journal-title":"Trop. J. Pharm. Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1002\/jps.23721","article-title":"Preparation and physicochemical: Characterization of acyclovir cocrystals with improved dissolution properties","volume":"102","author":"Bruni","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_139","first-page":"244","article-title":"Cocrystals of efavirenz with selected coformers: Preparation and characterization","volume":"4","author":"Chadha","year":"2012","journal-title":"Int. J. Pharm. Sci"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jps.24248","article-title":"Cocrystals of acyclovir with promising physicochemical properties","volume":"104","author":"Sarkar","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1021\/cg4007058","article-title":"New solid forms of the anti-HIV drug etravirine: Salts, cocrystals, and solubility","volume":"13","author":"Rajput","year":"2013","journal-title":"Cryst. Growth Des."},{"key":"ref_142","first-page":"556","article-title":"Utilization of co-crystallization for solubility enhancement of a poorly soluble antiretroviral drug-ritonavir","volume":"6","author":"Shah","year":"2004","journal-title":"Int. J. Pharm. Sci."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.matpr.2021.05.535","article-title":"Pharmaceutical cocrystals of efavirenz: Towards the improvement of solubility, dissolution rate and stability","volume":"51","author":"Gowda","year":"2022","journal-title":"Mater. Today Proc."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"43","DOI":"10.22270\/jddt.v11i1-s.4696","article-title":"Improvement of physicochemical and solubility of dipyridamole by cocrystallization technology","volume":"11","author":"Gawade","year":"2021","journal-title":"J. Drug Deliv. Ther."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1021\/acs.cgd.0c01673","article-title":"Cocrystallization of amantadine hydrochloride with resveratrol: The first drug-nutraceutical cocrystal displaying synergistic antiviral activity","volume":"21","author":"Wang","year":"2021","journal-title":"Cryst. Growth Des."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"6399","DOI":"10.1021\/cg501247x","article-title":"Pharmaceutical cocrystals of ribavirin with reduced release rates","volume":"14","author":"Chen","year":"2014","journal-title":"Cryst. Growth Des."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1039\/D1AN00478F","article-title":"Supramolecular self-assembly of amantadine hydrochloride with ferulic acid via dual optimization strategy establishes a precedent of synergistic antiviral drug-phenolic acid neutraceutical cocrystal","volume":"146","author":"Wang","year":"2021","journal-title":"Analyst"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"105883","DOI":"10.1016\/j.ejps.2021.105883","article-title":"A novel crystalline molecular salt of sulfamethoxazole and amantadine hybridizing antiviral-antibacterial dual drugs with optimal in vitro\/vivo pharmaceutical properties","volume":"163","author":"Wanga","year":"2021","journal-title":"Euro. J. Pharm. Sci."},{"key":"ref_149","first-page":"86","article-title":"Crystal engineering of antiviral agent efavirenz for solubility enhancement","volume":"8","author":"Gadade","year":"2018","journal-title":"Drug Deliv. Thera."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/24\/9051\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:43:58Z","timestamp":1760147038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/24\/9051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":149,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["molecules27249051"],"URL":"https:\/\/doi.org\/10.3390\/molecules27249051","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2022,12,19]]}}}